Skip to content

Depiction of Prostate Cancer Treatment Alternatives in Greece

Depiction of Prostate Cancer Treatment Alternatives in Greece

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00733213
Enrollment
310
Registered
2008-08-12
Start date
2008-01-31
Completion date
2009-03-31
Last updated
2009-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally Advanced or Metastatic Prostate Cancer.

Keywords

Prostate Cancer, Treatment alternatives, Metastasis

Brief summary

A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice. * Target Group: Patients with locally advanced or metastatic prostate cancer. * The first 10 consecutive patients records that meet the entry criteria.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with Locally advanced or Metastatic Prostate Cancer after 2002. * Patients that received Hormonal therapy.

Exclusion criteria

* Males that are aged less than 18 years

Design outcomes

Primary

MeasureTime frame
Percentage of patients treated by each treatment alternative.Between 2002 - 2008

Secondary

MeasureTime frame
To depict sociodemographic characteristics and comorbidities.Between 2002 - 2008

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026